Moneycontrol
HomeNewsBusinessCOVID-19: Around 80 workers at ONGC’s offshore facility test positive; no impact on production
Trending Topics

COVID-19: Around 80 workers at ONGC’s offshore facility test positive; no impact on production

Sources say the company continues to produce 50,000 barrels per day from the platform. Of the affected, 28 are ONGC employees. The rest are contract workers. Only two out of the six rigs in Mumbai high are currently operational.

May 03, 2021 / 12:01 IST
Story continues below Advertisement

When the entire country is reeling under COVID-19, nearly 176 km away from Mumbai west coast, in India’s largest oil field, Mumbai High, the state-owned Oil and Natural Gas Corporation (ONGC), too, is in a spot.

About 75-80 people, out of the total 230 or around 35 percent of the workforce, have been infected by COVID-19 in Heera, one of ONGC’s largest producing platforms. Out of this, 28 are ONGC employees. The rest are contract workers.

Story continues below Advertisement

The company claims production is unaffected and maintains that it is continuing to produce 50,000 barrels of oil per day from the platform. An ONGC spokesperson declined to comment on the development.

A source, who is working offshore, told Moneycontrol that only two rigs out of the six in the area are currently operational.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show